Pilot Study of Metformin in Head and Neck Squamous Cell Cancer and Its Effects on Stromal-epithelial Metabolic Uncoupling
EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment
50
Participants
Timeline
Start Date
September 5, 2013
Primary Completion Date
May 9, 2016
Study Completion Date
April 6, 2017
Conditions
Head and Neck Squamous Cell Cancer
Interventions
DRUG
Metformin
Trial Locations (1)
19107
Thomas Jefferson University, Philadelphia
All Listed Sponsors
lead
Sidney Kimmel Cancer Center at Thomas Jefferson University
OTHER
NCT02083692 - Pilot Study of Metformin in Head and Neck Squamous Cell Cancer and Its Effects on Stromal-epithelial Metabolic Uncoupling | Biotech Hunter | Biotech Hunter